MetaCap

Medpace (MEDP) vs OneMedNet (ONMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Medpace (MEDP) has outperformed OneMedNet (ONMD) over the past year, gaining 13.5% versus a loss of 79.0%. Over five years, MEDP leads with a +222.2% price change compared with -95.2% for ONMD. Medpace is the larger company by market cap ($16.82 billion vs $28.1 million), about 599.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MEDP+13.50%ONMD-79.04%
+42%-21%-85%
Oct 8, 20251 yearOct 8, 2026
MEDP+219.23%ONMD-95.20%
+245%+66%-113%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MEDP versus ONMD key metrics
MetricMEDPONMD
Share price$602.70$4.82
Market cap$16.82B$28.08M
1-day change-0.26%-1.83%
YTD return+7.31%-56.18%
1-year return+13.50%-79.04%
5-year return+222.16%-95.21%
P/E ratio (TTM)35.39—
Forward P/E31.20—
EPS (TTM)$17.03$-1.60
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.53B—
Revenue growth (YoY)+19.97%—
Net income (latest FY)$451.12M—
Operating margin21.14%—
Net margin17.83%—
52-week high$677.90$42.20
52-week low$373.00$4.73
Distance from 52-week high-11.09%-88.58%
Analyst consensushold—
Avg. price target upside-1.80%—
Average volume272.38K114.91K
Shares outstanding27.91M5.82M
Employees6,50022
SectorHealth CareHealth Care
IndustryBiotechnology: Commercial Physical & Biological ResarchBiotechnology: Commercial Physical & Biological Resarch

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Medpace is about 599.2 times larger than OneMedNet by market value ($16.82B vs $28.08M).
  • MEDP has outperformed ONMD by 92.5 percentage points over the past year.

About Medpace

MEDP stock →

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.

Health Care · Biotechnology: Commercial Physical & Biological Resarch · 6,500 employees

About OneMedNet

ONMD stock →

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets.

Health Care · Biotechnology: Commercial Physical & Biological Resarch · 22 employees

MEDP vs ONMD FAQ

Which is bigger, Medpace or OneMedNet?

Medpace (MEDP) is larger, with a market capitalization of $16.82B compared with $28.08M for OneMedNet (ONMD).

Which stock has performed better over the past year, MEDP or ONMD?

MEDP returned +13.50% over the past 12 months, compared with -79.04% for ONMD (price return, excluding dividends). Past performance does not predict future results.

Are Medpace and OneMedNet in the same industry?

Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.

More comparisons